Loading institutional data...
Loading institutional data...
Held by 180 of 5,944 reporting institutions (91th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $27.54 today, the market must believe free cash flow compounds -3.9%/yr for a decade (off $161M normalized FCF).
The market's -3.9% is more optimistic than its 9-yr track record.
2-stage DCF · 0.02B shares · net debt $762M
mean 65.9% · volatility σ 245% · implied rate exceeded in 4/9 yrs
Central path = implied -3.9%/yr growth; shaded band = ±1σ (245%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $852.5B | 39.1× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $396.2B | 49.1× | 30.3× | 1.4× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $378.9B | 29.0× | 24.9× | 7.9× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $346.8B | 22.7× | 16.4× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $296.4B | 26.2× | 17.3× | 7.3× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $183.0B | 22.3× | 14.9× | 1.9× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $116.7B | 16.9× | 13.6× | 5.0× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $80.3B | 32.8× | 18.9× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $72.4B | 19.7× | 10.5× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $70.3B | 33.4× | 19.6× | 3.5× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.5B | — | 16.4× | 5.3× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $42.7B | 20.5× | 14.3× | 2.6× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| ADM | $42.6B | 39.5× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| FMX | $41.0B | — | — | — | — | — | — | — | — | — | 290 |
| JBS | $39.7B | — | — | — | — | — | — | — | — | — | 241 |
| KR | $39.6B | 39.5× | 10.0× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| SYY | $38.6B | 21.2× | 9.7× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| KVUE | $34.2B | 23.5× | 11.7× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| HSY | $34.1B | — | 20.1× | 2.9× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| EL | $33.8B | — | 768.2× | 2.4× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| KMB | $32.6B | 16.2× | 10.3× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $29.3B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $27.5B | 18.2× | 8.1× | 0.6× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| KOF | $23.6B | — | — | — | — | — | — | — | — | — | 249 |
| CHD | $23.1B | 31.5× | 18.8× | 3.7× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.7× | 1,004 |
| HELE | $636M | — | — | 0.4× | -6.4% | 45.7% | -50.3% | -113% | -56.9% | -1.1× | 180 |
Peers = companies sharing HELE's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $2M buybacks = $2M returned on $132M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -57%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $19M is below the $25M due within a year — relies on refinancing or operating cash flow. Scheduled principal only (excludes interest & revolver draws). As of 2026-02-28 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~7.4% on $781M of debt.
Cash of $19M is below short-term debt of $25M — relies on refinancing/operations.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No standout strengths flagged.
Is the profit real, and how strong is the balance sheet?
FY2026 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 101.8× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 59.0 | 57.0 | 55.8 | 57.1 | 56.6 | 52.7 | 52.1 | 54.3 |
| Gross Profit | 41.0 | 43.0 | 44.2 | 42.9 | 43.4 | 47.3 | 47.9 | 45.7 |
| R&D | 0.8 | 1.0 | 2.5 | 2.4 | 2.3 | 2.8 | 2.8 | 3.0 |
| SG&A | 28.0 | 30.0 | 30.4 | 30.6 | 31.9 | 33.4 | 37.0 | 39.7 |
| Operating Income | 12.7 | 10.4 | 13.4 | 12.3 | 10.2 | 13.0 | 7.5 | -43.8 |
| Income Tax | 0.9 | 0.8 | 0.7 | 1.6 | 1.4 | 2.0 | -1.7 | 3.4 |
| Net Income | 10.8 | 8.9 | 12.1 | 10.1 | 6.9 | 8.4 | 6.5 | -50.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on HELE: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2026
Each value shows its share of revenue below it (common-size).
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.79B 100.0% | $1.91B 100.0% | $2.01B 100.0% | $2.07B 100.0% | $2.22B 100.0% | $2.10B 100.0% | $1.71B 100.0% | $1.56B 100.0% | $1.48B 100.0% | $1.40B 100.0% |
| Cost of Revenue | $970.6M 54.3% | $993.3M 52.1% | $1.06B 52.7% | $1.17B 56.6% | $1.27B 57.1% | $1.17B 55.8% | $973.0M 57.0% | $923.0M 59.0% | $867.6M 58.7% | $824.1M 59.0% |
| Cost of Products | — | — | — | — | — | — | — | — | $867.6M 58.7% | $824.1M 59.0% |
| Gross Profit | $815.7M 45.7% | $914.4M 47.9% | $948.7M 47.3% | $899.4M 43.4% | $953.2M 42.9% | $927.3M 44.2% | $734.5M 43.0% | $641.1M 41.0% | $611.2M 41.3% | $573.4M 41.0% |
| Research & Development | $54.0M 3.0% | $53.9M 2.8% | $56.5M 2.8% | $47.8M 2.3% | $54.0M 2.4% | $53.4M 2.5% | $17.8M 1.0% | $13.0M 0.8% | $13.5M 0.9% | $11.8M 0.8% |
| Selling, General & Admin | $708.9M 39.7% | $705.4M 37.0% | $669.4M 33.4% | $660.2M 31.9% | $680.3M 30.6% | $637.0M 30.4% | $511.9M 30.0% | $438.1M 28.0% | $424.8M 28.7% | $400.9M 28.7% |
| Operating Income | -$782.1M -43.8% | $142.7M 7.5% | $260.6M 13.0% | $211.8M 10.2% | $272.6M 12.3% | $281.5M 13.4% | $178.3M 10.4% | $199.4M 12.7% | $169.1M 11.4% | $169.7M 12.1% |
| Interest Expense | $57.7M 3.2% | $51.9M 2.7% | $53.1M 2.6% | $40.8M 2.0% | $12.8M 0.6% | $12.6M 0.6% | $12.7M 0.7% | $11.7M 0.7% | $14.0M 0.9% | $14.4M 1.0% |
| Other Income (Expense), net | $982K 0.1% | $838K 0.0% | $1.5M 0.1% | $249K 0.0% | $260K 0.0% | $559K 0.0% | $394K 0.0% | $340K 0.0% | $327K 0.0% | $414K 0.0% |
| Pretax Income | -$838.8M -47.0% | $91.7M 4.8% | $209.0M 10.4% | $171.3M 8.3% | $260.0M 11.7% | $269.4M 12.8% | $165.9M 9.7% | $188.0M 12.0% | $155.4M 10.5% | $155.7M 11.1% |
| Income Tax Expense | $60.1M 3.4% | -$32.1M -1.7% | $40.4M 2.0% | $28.0M 1.4% | $36.2M 1.6% | $15.5M 0.7% | $13.6M 0.8% | $13.8M 0.9% | $9.4M 0.6% | $11.4M 0.8% |
| Net Income | -$899.0M -50.3% | $124.0M 6.5% | $169.0M 8.4% | $143.0M 6.9% | $224.0M 10.1% | $253.9M 12.1% | $152.3M 8.9% | $168.5M 10.8% | $44.4M 3.0% | $140.7M 10.1% |
| Per Share | ||||||||||
| EPS (Basic) | $-39.08 | $5.38 | $7.06 | $5.98 | $9.27 | $10.16 | $6.06 | $6.46 | $1.64 | $5.11 |
| EPS (Diluted) | $-39.08 | $5.37 | $7.03 | $5.95 | $9.17 | $10.08 | $6.02 | $6.41 | $1.63 | $5.04 |
| Weighted Avg Shares (Basic) | 23.0M | 23.0M | 23.9M | 24.0M | 24.1M | 25.0M | 25.1M | 26.1M | 27.1M | 27.5M |
| Weighted Avg Shares (Diluted) | 23.0M | 23.1M | 24.0M | 24.1M | 24.4M | 25.2M | 25.3M | 26.3M | 27.3M | 27.9M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.